System-level immune and tissue microenvironment (TME)

The system-level immune and tissue microenvironment refers to the complex, multi-component ecosystem consisting of various cell types, signaling molecules, and structural elements that surround a specific tissue or pathological site. In oncology, this is frequently termed the tumor microenvironment (TME), which includes malignant cells, infiltrating immune cells (such as T cells and macrophages), stromal fibroblasts, and the vascular network (Nature Reviews Cancer, 2021). This environment is not a single molecular target but rather a dynamic network that regulates disease progression, immune evasion, and therapeutic resistance (NIH, 2023). Therapeutic interventions often aim to "reprogram" this environment—for instance, by blocking inhibitory checkpoints like PD-1 or inhibiting pro-angiogenic factors like VEGF—to shift the milieu from a suppressive to an active state (PubMed, 2022). Understanding the spatial and functional organization of this system is critical for the development of next-generation immunotherapies and personalized medicine strategies.

Other names

Tumor microenvironmentTMEImmune microenvironmentTissue nicheImmune macroenvironment

Drugs targeting components of this system typically act by inhibiting immunosuppressive checkpoints, neutralizing pro-angiogenic factors, or modulating cytokine signaling to alter the overall functional state of the tissue milieu (Nature Reviews Drug Discovery, 2020).